A biopsy-based genomic classifier to predict biochemical failure after definitive radiation without hormone therapy in a prospective cohort of intermediate risk prostate cancer.

被引：0
|
作者：
Chua, Melvin
Murgic, Jure
Hosni, Ali
Salcedo, Adriana
Kamel-Reid, Suzanne
Berlin, Alejandro
Pintile, Melania
Fraser, Michael
Van Der Kwast, Theodorus
Boutros, Paul Christopher
Bristow, Robert G.
机构：
[1] Natl Canc Ctr Singapore, Singapore, Singapore
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Ontario Inst Canc Res, Toronto, ON, Canada
[4] Univ Hlth Network, Toronto, ON, Canada
[5] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[6] Univ Toronto, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON, Canada
[7] Manchester Canc Res Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.68
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The 17-Gene Genomic Prostate Score Assay Is Prognostic for Biochemical Failure in Men With Localized Prostate Cancer After Radiation Therapy at a Community Cancer Center
    Canter, Daniel J.
    Branch, Caroline
    Shelnutt, Jason
    Foreman, Aimee J.
    Lehman, Amy M.
    Sama, Varun
    Edwards, David K.
    Abran, John
    ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (04)
  • [32] THE 17-GENE GENOMIC PROSTATE SCORE® ASSAY IS PROGNOSTIC FOR BIOCHEMICAL FAILURE IN MEN WITH LOCALIZED PROSTATE CANCER AFTER RADIATION THERAPY AT A COMMUNITY CANCER CENTER
    Canter, Daniel
    Branch, Caroline
    Zambon, Joao
    Groskopf, Jack
    Foreman, Aimee
    Lehman, Amy
    Sama, Varun
    Edwards, David
    Abran, John
    JOURNAL OF UROLOGY, 2023, 209 : E213 - E213
  • [33] The Effect of the Timing of Biochemical Failure after External Beam Radiation Therapy or Low Dose-rate Brachytherapy for Definitive Prostate Cancer Treatment
    Ciezki, J. P.
    Reddy, C. A.
    Mian, O. Y.
    Tendulkar, R. D.
    Ulchaker, J.
    Angermeier, K.
    Campbell, S.
    Stephenson, A. J.
    Klein, E. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E100 - E101
  • [34] The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation
    Ludwig, Michelle S.
    Kuban, Deborah A.
    Du, Xianglin L.
    Lopez, David S.
    Yamal, Jose-Miguel
    Strom, Sara S.
    BMC CANCER, 2015, 15
  • [35] The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation
    Michelle S Ludwig
    Deborah A Kuban
    Xianglin L Du
    David S Lopez
    Jose-Miguel Yamal
    Sara S Strom
    BMC Cancer, 15
  • [36] Cost-effectiveness of a biopsy-based 8-protein prognostic assay to optimize treatment decisions in intermediate-risk early-stage prostate cancer.
    Roth, Joshua A.
    Ramsey, Scott David
    Carlson, Josh John
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [37] The First Prostate Specific Antigen Value after Androgen Deprivation Therapy Initiation and after Definitive Radiation Therapy Completion As a Biomarker For Disease Relapse and Mortality in Intermediate and High Risk Prostate Cancer
    Patel, M. A.
    Kollmeier, M. A.
    McBride, S.
    Gorovets, D.
    Varghese, M.
    Knezevic, A.
    Zhigang, Z.
    Zelefsky, M. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E133 - E133
  • [38] PSA-based outcome analysis after radiation therapy for prostate cancer: A new definition of biochemical failure after intervention
    Jani, AB
    Chen, MH
    Vaida, F
    Ignacio, L
    Awan, A
    Weichselbaum, RR
    Vijayakumar, S
    UROLOGY, 1999, 54 (04) : 700 - 705
  • [39] A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
    Cullen, Jennifer
    Rosner, Inger L.
    Brand, Timothy C.
    Zhang, Nan
    Tsiatis, Athanasios C.
    Moncur, Joel
    Ali, Amina
    Chen, Yongmei
    Knezevic, Dejan
    Maddala, Tara
    Lawrence, H. Jeffrey
    Febbo, Phillip G.
    Srivastava, Shiv
    Sesterhenn, Isabell A.
    McLeod, David G.
    EUROPEAN UROLOGY, 2015, 68 (01) : 123 - 131
  • [40] Risk stratification and stage migration effect of novel imaging and biomarker technology in men with biochemical failure after local therapy for prostate cancer.
    Desai, B. B.
    Quinn, D. I.
    Piatek, C. I.
    Tang, R.
    Hu, J.
    Goldkorn, A.
    Gross, M. E.
    Hawes, D.
    Jadvar, H.
    Dorff, T. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345